These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8882984)

  • 1. Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
    Milano S; Zorzi F; Marini G; Zaniboni A; Ottoni DB; Di Fabio D; Mombelloni G
    Lung Cancer; 1996 Sep; 15(2):183-7. PubMed ID: 8882984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.
    Vansteenkiste JF; De Leyn PR; Deneffe GJ; Lievens YN; Nackaerts KL; Van Raemdonck DE; van der Schueren E; Lerut TE; Demedts MG
    Ann Oncol; 1998 Mar; 9(3):261-7. PubMed ID: 9602259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
    Masutani M; Akusawa H; Kadota A; Ohchi Y; Takahashi N; Tanigawa S; Koya Y; Horie T
    Respirology; 1996 Mar; 1(1):49-54. PubMed ID: 9432405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H; Miyahara R; Tanaka F; Hitomi S
    Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
    Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Rosell R; Maestre J; Font A; Moreno I; Molina F; Milla A; Gómez-Codina J; Camps C
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease extent and response to chemotherapy in non-small cell lung cancer.
    Satoh H; Yano H; Ishikawa H; Hasegawa S
    Acta Oncol; 1996; 35(1):106-7. PubMed ID: 8619933
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
    Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
    J Natl Cancer Inst; 2003 Oct; 95(19):1453-61. PubMed ID: 14519751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
    Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
    J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
    Vansteenkiste J; Vandebroek J; Mariën S; Roex L; Bertrand P; Bockaert J; De Beukelaar T; Deman R; De Muynck P; Ulrichts H
    Lung Cancer; 1995 Dec; 13(3):295-303. PubMed ID: 8719069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
    Mouillet G; Monnet E; Milleron B; Puyraveau M; Quoix E; David P; Ducoloné A; Molinier O; Zalcman G; Depierre A; Westeel V;
    J Thorac Oncol; 2012 May; 7(5):841-9. PubMed ID: 22722786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICE: a new active combination for non-small cell lung cancer.
    Arcangeli G; Zaniboni A; Milano S; Meriggi F; Simoncini E; Marpicati P; Marini G
    Eur J Cancer; 1993; 29A(13):1848-50. PubMed ID: 8260239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Nakagawa H; Imamura F; Minamigawa K; Kobayashi H
    Oncol Rep; 2001; 8(2):279-83. PubMed ID: 11182040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.
    Burkes RL; Ginsberg RJ; Shepherd FA; Blackstein ME; Goldberg ME; Waters PF; Patterson GA; Todd T; Pearson FG; Cooper JD
    J Clin Oncol; 1992 Apr; 10(4):580-6. PubMed ID: 1312587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
    Berghmans T; Meert AP; Ninane V; Sculier JP
    Monaldi Arch Chest Dis; 2005 Dec; 63(4):184-92. PubMed ID: 16454217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer.
    Pisters KM; Kris MG; Gralla RJ; Hilaris B; McCormack PM; Bains MS; Martini N
    J Surg Oncol; 1994 Aug; 56(4):236-41. PubMed ID: 8057649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
    Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.